Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Application US20200291434
Inmed Pharmaceuticals Inc.

Metabolic Engineering Of E. Coli For The Biosynthesis Of Cannabinoid Products

Provided herein are methods and compositions for producing terpenoids in a host cell. In some cases, the terpenoids are cannabinoids.

Much More than Average Length Specification


1 Independent Claims

  • Claim CLM-00001. 1. An expression cassette comprising a heterologous promoter operably linked to a nucleic acid encoding a bifunctional ispDF enzyme.
  • Claim CLM-00022. 22. A host cell comprising: a. an expression cassette comprising a heterologous promoter operably linked to a nucleic acid encoding a bifunctional ispDF enzyme; and b. an expression cassette comprising a heterologous promoter operably linked to a nucleic acid encoding a terpenoid synthase.


View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >



Patent Matrix® Search


USPTO Patent Document Number